Articles with public access mandates - Kirsten MertzLearn more
Not available anywhere: 8
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
L Bonapace, MM Coissieux, J Wyckoff, KD Mertz, Z Varga, T Junt, ...
Nature 515 (7525), 130-133, 2014
Mandates: Swiss National Science Foundation, UK Medical Research Council, European …
Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy
AL Correia, JC Guimaraes, P Auf der Maur, D De Silva, MP Trefny, ...
Nature 594 (7864), 566-571, 2021
Mandates: Swiss National Science Foundation, European Commission, Swiss Cancer League
pVHL co‐ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear‐cell renal cell carcinoma
K Struckmann, KD Mertz, S Steu, M Storz, P Staller, W Krek, P Schraml, ...
The Journal of pathology 214 (4), 464-471, 2008
Mandates: Swiss National Science Foundation
Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome
K Garg, M Maurer, J Griss, MC Brüggen, IH Wolf, C Wagner, N Willi, ...
Human pathology 54, 157-164, 2016
Mandates: Vienna Science and Technology Fund, Austria
Digital image analysis improves precision of PD‐L1 scoring in cutaneous melanoma
VH Koelzer, A Gisler, JC Hanhart, J Griss, SN Wagner, N Willi, ...
Histopathology 73 (3), 397-406, 2018
Mandates: Swiss National Science Foundation, Austrian Science Fund, Swiss Cancer League
A variant of a killer cell immunoglobulin-like receptor is associated with resistance to PD-1 blockade in lung cancer
MP Trefny, SI Rothschild, F Uhlenbrock, D Rieder, B Kasenda, ...
Clinical Cancer Research 25 (10), 3026-3034, 2019
Mandates: Swiss National Science Foundation, Swiss Cancer Foundation, Swiss Cancer League
Using autopsies to dissect COVID-19 pathogenesis
F Heinrich, KD Mertz, M Glatzel, M Beer, S Krasemann
Nature Microbiology 8 (11), 1986-1994, 2023
Mandates: Federal Ministry of Education and Research, Germany
Tracing tumor heterogeneity of pleomorphic carcinoma of the lung
L Roma, C Ercan, F Conticelli, N Akyürek, SS Prince, KD Mertz, J Diebold, ...
Journal of Thoracic Oncology, 2024
Mandates: Swiss National Science Foundation
Available somewhere: 48
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
DS Thommen, VH Koelzer, P Herzig, A Roller, M Trefny, S Dimeloe, ...
Nature medicine 24 (7), 994-1004, 2018
Mandates: Swiss National Science Foundation, European Commission, Dutch Cancer Society
Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney
R Beroukhim, JP Brunet, A Di Napoli, KD Mertz, A Seeley, MM Pires, ...
Cancer research 69 (11), 4674-4681, 2009
Mandates: Swiss National Science Foundation, US National Institutes of Health
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
SR Setlur, KD Mertz, Y Hoshida, F Demichelis, M Lupien, S Perner, ...
Journal of the National Cancer Institute 100 (11), 815-825, 2008
Mandates: Swiss National Science Foundation, US National Institutes of Health
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma
J Griss, W Bauer, C Wagner, M Simon, M Chen, ...
Nature communications 10 (1), 4186, 2019
Mandates: US Department of Defense, US National Institutes of Health, Austrian Science …
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications
JM Mosquera, S Perner, EM Genega, M Sanda, MD Hofer, KD Mertz, ...
Clinical Cancer Research 14 (11), 3380-3385, 2008
Mandates: US National Institutes of Health, German Research Foundation
Morphological features of TMPRSS2–ERG gene fusion prostate cancer
JM Mosquera, S Perner, F Demichelis, R Kim, MD Hofer, KD Mertz, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2007
Mandates: German Research Foundation
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model
KD Mertz, SR Setlur, SM Dhanasekaran, F Demichelis, S Perner, ...
Neoplasia 9 (3), 200-IN3, 2007
Mandates: German Research Foundation
Placental pathology findings during and after SARS-CoV-2 infection: features of villitis and malperfusion
T Menter, KD Mertz, S Jiang, H Chen, C Monod, A Tzankov, S Waldvogel, ...
Pathobiology 88 (1), 69-77, 2021
Mandates: Bill & Melinda Gates Foundation
Precision immunoprofiling by image analysis and artificial intelligence
VH Koelzer, K Sirinukunwattana, J Rittscher, KD Mertz
Virchows Archiv 474 (4), 511-522, 2019
Mandates: Swiss National Science Foundation, UK Engineering and Physical Sciences …
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα
A Britschgi, S Duss, S Kim, JP Couto, H Brinkhaus, S Koren, D De Silva, ...
Nature 541 (7638), 541-545, 2017
Mandates: Swiss National Science Foundation, European Commission, Swiss Cancer League
The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice
KD Mertz, LF Mager, MH Wasmer, T Thiesler, VH Koelzer, G Ruzzante, ...
Oncoimmunology 5 (1), e1062966, 2016
Mandates: Swiss National Science Foundation
SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages
GJ Martínez-Colón, K Ratnasiri, H Chen, S Jiang, E Zanley, A Rustagi, ...
Science Translational Medicine 14 (674), eabm9151, 2022
Mandates: US National Science Foundation, Swiss National Science Foundation, Bill …
Publication and funding information is determined automatically by a computer program